Business
Novo Nordisk Announces 50 Percent List Price Cut for GLP-1 Drugs to Expand Patient Access
Pharmaceutical leader Novo Nordisk is slashing list prices for its blockbuster GLP-1 medications by up to 50 percent in the United States. The strategic move is designed to reduce out-of-pocket expenses for insured patients navigating high-deductible health plans.
February 24, 2026428 views
Score-1
Enjoyed this story? Share it! 👇
Advertisement
Related Stories
Business
Wellness Franchises Drive 2026 Economic Growth as Membership Models Replace Fast Food Dominance
1d ago
Business
Morgan Wallen Secures Twentieth No. 1 with '20 Cigarettes' as Country Airplay Milestone Reshapes History
1d ago
Business
Michael Burry Issues 'Catastrophic' Risk Warning Over Nvidia Market Position
1d ago
Business
The Quarter-Salary Sacrifice: New Study Reveals the Steep Price Workers Pay for Remote Freedom
1d ago
Comments (0)
Sign in to leave a comment.
No comments yet. Be the first to share your thoughts!